Flagship Pioneering-backed Alltrna is once again laying off staff, this time reducing its workforce by 19 people. | Flagship ...
The market seems to be falling heavily out of love with the AI stocks, and for good reason: CapEx is rising at a staggering ...
2don MSN
2 biotech giants to buy in 2026
Both of these players are leaders in their fields.
With fresh billions unlocked in the 2026 U.S. budget and mission‑driven family offices recalibrating after a “nuclear winter, ...
Tomorrow BioTech and Green2Gold unite to support biotech and green innovators with labs, mentorship, and a path to ...
The companies Vaxcyte, Generate Biomedicines, and Immunic bagged the biggest biotech funding rounds overall in February 2026.
Transformative Biotech LLC, a Boulder-based company working to develop faster molecular tests for diseases such as COVID-19 and cancer, has appointed Mark Kelleher as executive vice president of ...
Should include detailed information, to the extent practicable, on the degree of subsidization and market overcapacity by Chinese biotechnology firms and its impact on U.S. industry, including genomic ...
Each morning for eight weeks, Douley Olivier dragged himself out of bed at 5 a.m. to drop his girlfriend at work so he could drive her car across Dorchester to train as a lab technician in the ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
February 2026 saw a major biopharma acquisition, four key buyouts, and licensing deals in antibodies, small molecules, and ...
Welcome to Fierce Biotech's fifth annual layoff tracker, a resource designed to keep pace with the sector's steady stream of workforce reductions. In 2025, industry layoffs continued to rise year over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results